Studies of living participants and postmortem brains confirm that gene expansion is a promising target for HD prevention ...
Researchers have discovered that mouse PD-1 is significantly weaker than human PD-1, calling into question their reliability ...
This executive interview, sponsored by BeiGene, is with Jan-Henrik Terwey, Vice President, Medical Affairs Europe at BeiGene.
GlobalData on MSN2d
Evaxion concludes subject dosing in Phase II trial of melanoma vaccineEvaxion Biotech has completed subject dosing in the Phase II trial of its personalised peptide-based cancer vaccine, EVX-01, ...
Sarclisa obtains first approval in China for the treatment of adult patients with relapsed or refractory multiple myelomaApproval based on ...
China NMPA approves Sanofi’s Sarclisa in combo with pomalidomide and dexamethasone to treat adult patients with R/R multiple myeloma: Paris Tuesday, January 14, 2025, 10:00 Hrs ...
Cell biology is ... non-immunogenic cell-death modes, with biomedical potential. Tao et al. show that epidermal growth factor receptor and insulin-like growth factor 1 receptor activation enhances ...
As the year unfolds the biotech industry will look closely at these ten first-in-class drugs on track to reach FDA approval ...
Pfizer’s sasanlimab in combo with BCG improves EFS in patients with BCG-naïve, high-risk non-muscle invasive bladder cancer: New York Monday, January 13, 2025, 13:00 Hrs [IST] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback